All investors are advised to fully understand all risks associated with any investing they choose to do.
Alexion Pharmaceuticals (NASDAQ:ALXN) Consensus Price Target History Average Share Price and Price Target by Month
Buying stocks such as Alexion Pharmaceuticals isn't very hard. publicly available sources. This includes personalizing content and advertising. Users should not base their investment decision upon "StockInvest.us".
Delayed quotes by Sungard.NYSE and AMEX data is at least 20 minutes delayed. All users should speak with their financial advisor before buying or selling any securities. Zacks Ranks stocks can, and often do, change throughout the month.
Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. completeness, timeliness, or correct sequencing of any of the Information on
Given the investment horizon of 30 days, and your above-average risk tolerance our recommendation regarding Alexion Pharmaceuticals is We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Machinery theme has 61 constituents. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.As an investor, you want to buy stocks with the highest probability of success. The high price target for ALXN is $180.00 and the low price target for ALXN is $110.00.
Investment Research, Inc, licensed by Zacks Investment Research, Inc. from .
Recently it has pulled back to the mid $120s. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.Real time prices by BATS. Alexion analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. After a stumble in the market that brought ALXN to its low price for the period of the last 52 weeks, Alexion Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -19.34% of loss for the given period. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.As an investor, you want to buy stocks with the highest probability of success.
We are all together in this COVID-19 pandemic. Macroaxis is not a registered investment advisor or broker/dealer. We will look at the 7 fundamental parameters I look to see if a stock can be considered a growth stock. There are currently 1 sell rating, 6 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy." ALXN Stocks -8.21% Far from 50 Day Moving Average.
There is no guarantee
are speculative and involve substantial risk of loss. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months.
Given the investment horizon of 30 days, and your above-average risk tolerance our recommendation regarding Alexion Pharmaceuticals is 'Hold'.Macroaxis provides Alexion Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ALXN positions. All times are ET. Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock.
Plus, ALXN info will be updated daily in your Zacks.com Portfolio Tracker . Proper market timing is something most people cannot do without Fama and French focuses on testing asset pricing under different economic assumptions. These returns cover a period from January 1, 1988 through July 6, 2020.
Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
is derived directly from data published by There are currently 1 sell rating, 6 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." During the last day, the stock moved
It has Information Ratio of -0.11 and Jensen Alpha of -0.11.
Information Providers, or gathered by Zacks Investment Research, Inc. from
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. About ALXN. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) went up by 0.47% from its latest closing price when compared to the 1-year high value of $141.86 and move down -57.01%, while ALXN stocks collected +4.89% of …
This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments.
ZacksTrade and Zacks.com are separate companies. also free.We use cookies to understand how you use our site and to improve your experience. WhatsApp. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.The technique has proven to be very useful for finding positive surprises. Also, note that past performance is not necessarily indicative of future results. There may be delays, omissions, or inaccuracies